European regulators recommend expanding once-weekly growth hormone therapy to include children born small for gestational age ...

Growth hormone treatment is a safe and effective therapy that’s often used to treat children and adults with a deficiency in human growth hormone (also known as HGH or somatropin). Naturally-occurring ...

Add Yahoo as a preferred source to see more of our stories on Google. Human growth hormone (HGH) is a hormone that’s essential to our development. Most people produce enough HGH throughout their ...

Novo Nordisk A/S (NYSE:NVO) on Monday presented data from the phase 3 REAL8 basket study investigating once-weekly Sogroya (somapacitan) in four different but related growth disorder indications, ...

Ascendis Pharma announced positive results from the Week 26 analysis of its Phase 2 trial, New InsiGHTS, which studied once-weekly TransCon hGH for prepubertal children with Turner syndrome. The trial ...

Ascendis Pharma A/S (NASDAQ:ASND) is among the 13 Biotech Stocks with Huge Upside Potential. It reported interim Week 26 data from its Phase 2 COACH Trial, confirming that combining TransCon hGH ...

Sermorelin is a synthetic form of growth hormone-releasing hormone (GHRH), used to raise levels of human growth hormone (hGH). It’s currently not available in the U. S. as an FDA-approved medication, ...

Ascendis Pharma's supplemental application for SKYTROFA in adult GHD has been accepted by the FDA, aiming for broader patient access. Acceptance of the sBLA does not guarantee approval; the company ...